StockNews.com started coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research note published on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, William Blair reissued a market perform rating on shares of FibroGen in a report on Monday, June 3rd. Get Our Latest Research Report on FibroGen […]

Analysts at StockNews.com began coverage on shares of Broadway Financial (NASDAQ:BYFC – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the savings and loans company’s stock. Broadway Financial Trading Up 0.5 % Shares of NASDAQ BYFC opened at $6.15 on Friday. The business has a […]

Raymond James began coverage on shares of Airbnb (NASDAQ:ABNB – Free Report) in a research report released on Friday morning, Marketbeat.com reports. The firm issued a market perform rating and a $134.00 target price on the stock. Several other brokerages have also recently weighed in on ABNB. Truist Financial dropped their target price on Airbnb […]

Equities researchers at StockNews.com started coverage on shares of Allied Healthcare Products (NASDAQ:AHPI – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating on the medical equipment provider’s stock. Allied Healthcare Products Stock Performance Allied Healthcare Products has a fifty-two week low of $0.00 and a fifty-two week high […]

Equities researchers at Raymond James initiated coverage on shares of Achieve Life Sciences (NASDAQ:ACHV – Get Free Report) in a note issued to investors on Friday, MarketBeat reports. The brokerage set a “strong-buy” rating and a $20.00 price target on the biopharmaceutical company’s stock. Raymond James’ target price indicates a potential upside of 319.29% from […]

StockNews.com started coverage on shares of Rave Restaurant Group (NASDAQ:RAVE – Free Report) in a research report released on Wednesday. The firm issued a buy rating on the restaurant operator’s stock. Rave Restaurant Group Trading Down 1.9 % Shares of NASDAQ RAVE opened at $2.06 on Wednesday. Rave Restaurant Group has a 12-month low of […]

Raymond James began coverage on shares of LENZ Therapeutics (NASDAQ:LENZ – Free Report) in a report released on Friday, MarketBeat.com reports. The firm issued an outperform rating and a $37.00 target price on the stock. Other equities research analysts have also recently issued research reports about the company. HC Wainwright began coverage on LENZ Therapeutics […]